Destiny Pharma Seeks Partner For Lead Asset XF-73

Destiny CEO Believes Superbug Gel Will Draw Backing

 
• By Sten Stovall
  
Bacteria
Destiny's nasal gel is for preventing post-surgical infections from Staphylococcus aureus. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip